查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1946980

2026年全球即时血液学诊断市场报告

Point Of Care Hematology Diagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，照护现场血液学诊断市场发展迅速，预计将从2025年的29亿美元成长到2026年的31.6亿美元，复合年增长率达9.0%。过去几年成长要素包括：对中心检查室的高度依赖、贫血和血液疾病患病率的上升、急诊入院人数的增加、对快速诊断结果的需求以及农村地区检测设施的匮乏。

预计未来几年，照护现场血液学诊断市场将维持强劲成长，2030年市场规模将达到43.9亿美元，复合年增长率（CAGR）为8.6%。预测期内的成长要素包括慢性病和感染疾病病率的上升、就地检验项目的扩展、急诊室对快速诊断需求的增长、小型血液分析仪的技术进步以及分散式医疗服务模式的兴起。预测期内的主要趋势包括：床边快速血液检测的普及、急诊室对分散式诊断需求的增长、携带式和手持式血液学设备的使用增加、资源匮乏地区就地检验的扩展，以及注重为临床决策提供快速结果。

预计未来几年，血液疾病盛行率的不断上升将推动照护现场血液学诊断市场的成长。血液疾病是指影响血液成分（如红血球、白血球、血小板和血浆）的病理状况。其发生率的上升主要是由于直接影响血液健康且需要持续监测的慢性疾病的增加。照护现场血液学诊断可在患者照护时或附近提供快速且准确的结果，从而实现及时检测和监测，进而加速临床决策并改善疾病管理。例如，根据美国癌症协会2025年3月发布的数据，预计将有约22,010例急性骨髓性白血病（AML）病例被诊断出来（主要为成人），并导致约11,090例死亡。 AML约占成人白血病病例的三分之一，约占所有癌症病例的1%。血液疾病发生率的上升正在推动照护现场血液学诊断市场的成长。

该市场的主要企业正在开发先进的解决方案，例如基于试剂盒的AI赋能血液分析仪，以实现快速、准确的现场血液分析。这些紧凑型设备利用一次性试剂盒和人工智慧演算法，可在照护现场直接进行血液常规检查(CBC) 和其他分析。例如，2024年9月，总部位于美国的动物保健公司硕腾 (Zoetis Inc.) 推出了Vetscan OptiCell，这是一款用于兽医领域的基于试剂盒的AI赋能血液分析仪。该系统可在数分钟内提供快速、参考级的CBC结果，同时最大限度地减少维护和人工操作时间。 AI驱动的影像分析和黏弹性聚焦技术可实现精确的细胞定位、血球分类和自动异常检测，确保可靠、高效的诊断。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球即时血液学诊断市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施和互联生态系统
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
  • 主要趋势
    • 扩大床边快速血液检测的应用
    • 紧急医疗环境中对分散式诊断的需求日益增长
    • 携带式和手持式血液检测设备的使用日益增多
    • 在资源匮乏地区扩大就地检验
    • 重点在于缩短时间，以便为临床决策提供快速结果。

第五章 终端用户产业市场分析

  • 诊断中心
  • 医院
  • 血库
  • 输血中心
  • 初级保健诊所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球即时血液学诊断市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球即时血液学诊断市场规模、比较及成长率分析
  • 全球即时血液学诊断市场表现：规模与成长，2020-2025年
  • 全球即时血液学诊断市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按类型
  • 血液常规检查、血液凝固检验、血红素检查、贫血诊断及其他类型
  • 透过处方方法
  • 处方笺和非处方药
  • 最终用户
  • 诊断中心、医院、血库、输血中心和其他最终用户
  • 按类型细分：血液常规检查
  • 白血球计数、红血球计数、血小板计数、血球比容、血红素浓度、平均红血球体积（MCV）
  • 按类型细分：血液凝固检验
  • 凝血酶原时间（PT）、活化部份凝血活酵素时间（aPTT）、国际标准化比值（INR）、D-二聚体检测、纤维蛋白原水平
  • 按类型细分：血红素检测
  • 总血红素、醣化血红素（HbA1c）、氧合血红素、碳氧血红素、高铁血红素
  • 按类型细分：贫血诊断
  • 铁代谢检查、维生素B12浓度、叶酸浓度、网状红血球计数、铁蛋白检查、转铁蛋白饱和度
  • 按类型细分：其他类型
  • 血型鑑定及交叉反应性检测、红血球沉积速率检测、疟疾原虫检测、镰状细胞疾病筛检、C反应蛋白检测

第十章 区域与国家分析

  • 全球即时血液学诊断市场：区域分析、预测及成长，2020-2025年、2025-2030年预测、2035年预测
  • 全球即时血液学诊断市场：国家、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 即时血液学诊断市场：竞争格局及市占率预测（至2024年）
  • 即时血液学诊断市场：公司估值矩阵
  • 即时血液学诊断市场：公司概况
    • F. Hoffmann-La Roche Ltd.
    • Abbott Laboratories
    • Danaher Corporation
    • Siemens Healthineers AG
    • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.

第37章：其他领先和创新企业

  • Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., SD Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., BioMedomics Inc., PixCell Medical Technologies Ltd., Boule Diagnostics AB, Nihon Kohden Corporation, Edan Instruments Inc., A Menarini Industrie Farmaceutiche Srl, Becton Dickinson and Company, Ortho Clinical Diagnostics, Khema Diagnostics, Bio-Rad Laboratories Inc.

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年即时血液学诊断市场：提供新机会的国家
  • 2030年即时血液学诊断市场：蕴藏新机会的细分市场
  • 2030年即时血液学诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MPCHD01_G26Q1

Point-of-care hematology diagnostics refer to medical tests conducted at or near the site of patient care to quickly evaluate blood-related conditions, such as anemia, infections, or clotting disorders. These tests deliver rapid and accurate hematological results to support timely clinical decisions, particularly in emergency or resource-limited settings. This approach minimizes the reliance on centralized laboratory testing and accelerates diagnosis and treatment.

The primary types of point-of-care hematology diagnostics include complete blood count (CBC), coagulation testing, hemoglobin testing, anemia diagnosis, and others. A CBC measures various blood components, including red blood cells, white blood cells, hemoglobin, hematocrit, and platelets, helping to assess overall health and detect a wide range of disorders. These diagnostics are available as consumables and systems and are offered in both prescription-based and over-the-counter formats, serving end users such as diagnostic centers, hospitals, blood banks, transfusion centers, and other healthcare facilities.

Tariffs are impacting the point of care hematology diagnostics market by increasing costs of imported diagnostic systems, reagents, and electronic components used in compact analyzers. Consumables and system segments are most affected, particularly in Asia-Pacific and Latin American regions that rely heavily on imported diagnostic devices. These cost pressures have influenced pricing and procurement decisions for hospitals and diagnostic centers. However, tariffs have also encouraged local manufacturing, regional sourcing of consumables, and innovation in cost-effective point of care diagnostic solutions.

The point of care hematology diagnostics market research report is one of a series of new reports from The Business Research Company that provides point of care hematology diagnostics market statistics, including point of care hematology diagnostics industry global market size, regional shares, competitors with a point of care hematology diagnostics market share, detailed point of care hematology diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the point of care hematology diagnostics industry. This point of care hematology diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point of care hematology diagnostics market size has grown strongly in recent years. It will grow from $2.9 billion in 2025 to $3.16 billion in 2026 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to dependence on centralized laboratory testing, increasing burden of anemia and blood disorders, growth in hospital emergency admissions, need for faster diagnostic turnaround, limited access to laboratory infrastructure in rural areas.

The point of care hematology diagnostics market size is expected to see strong growth in the next few years. It will grow to $4.39 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rising prevalence of chronic and infectious diseases, expansion of point of care testing programs, increasing demand for rapid diagnostics in emergency care, technological advancements in compact hematology analyzers, growth in decentralized healthcare delivery models. Major trends in the forecast period include rising adoption of rapid bedside blood testing, growing demand for decentralized diagnostics in emergency settings, increasing use of portable and handheld hematology devices, expansion of point of care testing in resource-limited areas, focus on faster turnaround time for clinical decision-making.

The increasing prevalence of blood disorders is expected to drive the growth of the point-of-care hematology diagnostics market in the coming years. Blood disorders are conditions that affect components of the blood, including red blood cells, white blood cells, platelets, or plasma. Their rising incidence is largely due to the growing prevalence of chronic diseases, which directly impact blood health and necessitate ongoing monitoring. Point-of-care hematology diagnostics facilitate timely detection and monitoring by delivering rapid, accurate results at or near the site of patient care, enabling faster clinical decisions and improved disease management. For example, in March 2025, the American Cancer Society, a U.S.-based non-profit organization, reported that approximately 22,010 individuals are expected to be diagnosed with acute myeloid leukemia (AML), predominantly in adults, with around 11,090 projected deaths. AML accounts for roughly one-third of adult leukemia cases and about 1% of all cancers. Consequently, the rising incidence of blood disorders is propelling the growth of the point-of-care hematology diagnostics market.

Key companies in this market are developing advanced solutions, such as cartridge-based AI-powered hematology analyzers, to deliver rapid and precise on-site blood analysis. These compact devices utilize single-use reagent cartridges and artificial intelligence algorithms to perform complete blood counts (CBC) and other analyses directly at the point of care. For instance, in September 2024, Zoetis Inc., a US-based veterinary health company, launched Vetscan OptiCell, a cartridge-based, AI-powered hematology analyzer for veterinary use. This system provides rapid, reference-quality CBC results within minutes, while minimizing maintenance and hands-on time. It features AI-driven image analysis and viscoelastic focusing technology to accurately align cells, classify blood cells, and automatically detect abnormalities, ensuring reliable and efficient diagnostics.

In June 2023, Mars Inc., a US-based pet company, acquired Heska Corporation for an undisclosed amount. This acquisition expands Mars' veterinary diagnostics capabilities and strengthens its position in advanced animal healthcare by leveraging Heska's point-of-care hematology and specialty diagnostic solutions. Heska Corporation is a US-based veterinary diagnostics company offering point-of-care (POC) hematology diagnostics.

Major companies operating in the point of care hematology diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., BioMedomics Inc., PixCell Medical Technologies Ltd., Boule Diagnostics AB, Nihon Kohden Corporation, Edan Instruments Inc., A Menarini Industrie Farmaceutiche Srl, Becton Dickinson and Company, Ortho Clinical Diagnostics, Khema Diagnostics, Bio-Rad Laboratories Inc.

North America was the largest region in the point of care hematology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care hematology diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the point of care hematology diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The point of care hematology diagnostics market consists of revenues earned by entities by providing services such as rapid blood testing, decentralized diagnostic solutions, and home-based blood monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The point of care hematology diagnostics market also includes sales of portable hematology analyzers, cartridges and test kits, lancets, and reagents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point Of Care Hematology Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses point of care hematology diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point of care hematology diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point of care hematology diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Complete Blood Count; Coagulation Testing; Hemoglobin Testing; Anemia Diagnosis; Other Types
  • 2) By Mode Of Prescription: Prescription Based Product; Over-The-Counter Based Product
  • 3) By End User: Diagnostic Centers; Hospitals; Blood Banks; Transfusion Centers; Other End Users
  • Subsegments:
  • 1) By Complete Blood Count: White Blood Cell Count; Red Blood Cell Count; Platelet Count; Hematocrit; Hemoglobin Concentration; Mean Corpuscular Volume (MCV)
  • 2) By Coagulation Testing: Prothrombin Time (PT); Activated Partial Thromboplastin Time (aPTT); International Normalized Ratio (INR); D-Dimer Test; Fibrinogen Level
  • 3) By Hemoglobin Testing: Total Hemoglobin; Glycated Hemoglobin (HbA1c); Oxyhemoglobin; Carboxyhemoglobin; Methemoglobin
  • 4) By Anemia Diagnosis: Iron Studies; Vitamin B12 Levels; Folate Levels; Reticulocyte Count; Ferritin Test; Transferrin Saturation
  • 5) By Other Types: Blood Typing And Crossmatching; Erythrocyte Sedimentation Rate; Malaria Parasite Detection; Sickle Cell Screening; C-Reactive Protein Testing
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; Sysmex Corporation; HORIBA Ltd.; Nova Biomedical Corp.; S.D. Sight Diagnostics Ltd.; EKF Diagnostics Holdings plc.; BioMedomics Inc.; PixCell Medical Technologies Ltd.; Boule Diagnostics AB; Nihon Kohden Corporation; Edan Instruments Inc.; A Menarini Industrie Farmaceutiche Srl; Becton Dickinson and Company; Ortho Clinical Diagnostics; Khema Diagnostics; Bio-Rad Laboratories Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Point Of Care Hematology Diagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Point Of Care Hematology Diagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Point Of Care Hematology Diagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Point Of Care Hematology Diagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.4 Biotechnology, Genomics & Precision Medicine
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Rapid Bedside Blood Testing
    • 4.2.2 Growing Demand For Decentralized Diagnostics In Emergency Settings
    • 4.2.3 Increasing Use Of Portable And Handheld Hematology Devices
    • 4.2.4 Expansion Of Point Of Care Testing In Resource-Limited Areas
    • 4.2.5 Focus On Faster Turnaround Time For Clinical Decision-Making

5. Point Of Care Hematology Diagnostics Market Analysis Of End Use Industries

  • 5.1 Diagnostic Centers
  • 5.2 Hospitals
  • 5.3 Blood Banks
  • 5.4 Transfusion Centers
  • 5.5 Primary Healthcare Clinics

6. Point Of Care Hematology Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Point Of Care Hematology Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Point Of Care Hematology Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Point Of Care Hematology Diagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Point Of Care Hematology Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Point Of Care Hematology Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Point Of Care Hematology Diagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Point Of Care Hematology Diagnostics Market Segmentation

  • 9.1. Global Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Complete Blood Count, Coagulation Testing, Hemoglobin Testing, Anemia Diagnosis, Other Types
  • 9.2. Global Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Prescription Based Product, Over-The-Counter Based Product
  • 9.3. Global Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Centers, Hospitals, Blood Banks, Transfusion Centers, Other End Users
  • 9.4. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Complete Blood Count, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • White Blood Cell Count, Red Blood Cell Count, Platelet Count, Hematocrit, Hemoglobin Concentration, Mean Corpuscular Volume (MCV)
  • 9.5. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Coagulation Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), International Normalized Ratio (INR), D-Dimer Test, Fibrinogen Level
  • 9.6. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Hemoglobin Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Total Hemoglobin, Glycated Hemoglobin (HbA1c), Oxyhemoglobin, Carboxyhemoglobin, Methemoglobin
  • 9.7. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Anemia Diagnosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Iron Studies, Vitamin B12 Levels, Folate Levels, Reticulocyte Count, Ferritin Test, Transferrin Saturation
  • 9.8. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Typing And Crossmatching, Erythrocyte Sedimentation Rate, Malaria Parasite Detection, Sickle Cell Screening, C-Reactive Protein Testing

10. Point Of Care Hematology Diagnostics Market Regional And Country Analysis

  • 10.1. Global Point Of Care Hematology Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Point Of Care Hematology Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Point Of Care Hematology Diagnostics Market

  • 11.1. Asia-Pacific Point Of Care Hematology Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Point Of Care Hematology Diagnostics Market

  • 12.1. China Point Of Care Hematology Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Point Of Care Hematology Diagnostics Market

  • 13.1. India Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Point Of Care Hematology Diagnostics Market

  • 14.1. Japan Point Of Care Hematology Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Point Of Care Hematology Diagnostics Market

  • 15.1. Australia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Point Of Care Hematology Diagnostics Market

  • 16.1. Indonesia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Point Of Care Hematology Diagnostics Market

  • 17.1. South Korea Point Of Care Hematology Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Point Of Care Hematology Diagnostics Market

  • 18.1. Taiwan Point Of Care Hematology Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Point Of Care Hematology Diagnostics Market

  • 19.1. South East Asia Point Of Care Hematology Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Point Of Care Hematology Diagnostics Market

  • 20.1. Western Europe Point Of Care Hematology Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Point Of Care Hematology Diagnostics Market

  • 21.1. UK Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Point Of Care Hematology Diagnostics Market

  • 22.1. Germany Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Point Of Care Hematology Diagnostics Market

  • 23.1. France Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Point Of Care Hematology Diagnostics Market

  • 24.1. Italy Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Point Of Care Hematology Diagnostics Market

  • 25.1. Spain Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Point Of Care Hematology Diagnostics Market

  • 26.1. Eastern Europe Point Of Care Hematology Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Point Of Care Hematology Diagnostics Market

  • 27.1. Russia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Point Of Care Hematology Diagnostics Market

  • 28.1. North America Point Of Care Hematology Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Point Of Care Hematology Diagnostics Market

  • 29.1. USA Point Of Care Hematology Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Point Of Care Hematology Diagnostics Market

  • 30.1. Canada Point Of Care Hematology Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Point Of Care Hematology Diagnostics Market

  • 31.1. South America Point Of Care Hematology Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Point Of Care Hematology Diagnostics Market

  • 32.1. Brazil Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Point Of Care Hematology Diagnostics Market

  • 33.1. Middle East Point Of Care Hematology Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Point Of Care Hematology Diagnostics Market

  • 34.1. Africa Point Of Care Hematology Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Point Of Care Hematology Diagnostics Market, Segmentation By Type, Segmentation By Mode Of Prescription, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Point Of Care Hematology Diagnostics Market Regulatory and Investment Landscape

36. Point Of Care Hematology Diagnostics Market Competitive Landscape And Company Profiles

  • 36.1. Point Of Care Hematology Diagnostics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Point Of Care Hematology Diagnostics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Point Of Care Hematology Diagnostics Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Shenzhen Mindray Bio-Medical Electronics Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Point Of Care Hematology Diagnostics Market Other Major And Innovative Companies

  • Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., BioMedomics Inc., PixCell Medical Technologies Ltd., Boule Diagnostics AB, Nihon Kohden Corporation, Edan Instruments Inc., A Menarini Industrie Farmaceutiche Srl, Becton Dickinson and Company, Ortho Clinical Diagnostics, Khema Diagnostics, Bio-Rad Laboratories Inc.

38. Global Point Of Care Hematology Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Point Of Care Hematology Diagnostics Market

40. Point Of Care Hematology Diagnostics Market High Potential Countries, Segments and Strategies

  • 40.1 Point Of Care Hematology Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Point Of Care Hematology Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Point Of Care Hematology Diagnostics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer